Identify the host genetic determinants of immune response and TB countrol
Identify the host genetic determinants of immune response and TB countrol
批准号:
10089387
负责人:
MEGAN B MURRAY
金额:
$57.92万
依托单位国家:
美国
项目类别:
财政年份:
2015
资助国家:
美国
项目状态:
已结题
起止时间:
2015-02-01 至 2022-01-31
关键词:
AcuteAdjuvantAnimal ModelAntigen PresentationAntigensBypassCaviaCell physiologyClassificationClinicalDataDevelopmentDiseaseDisease ProgressionFormulationGene Expression ProfilingGenesGeneticGenetic DeterminismHouseholdHumanImmuneImmune responseImmunodiagnosticsImmunological DiagnosisImmunologicsImmunotherapyIndividualInfectionLipidsMHC antigenMagnetic Resonance ImagingMeasurementMeasuresMediatingMetabolicMethodsMolecularMucous MembraneOutcomePatientsPeptide/MHC ComplexPersonsPeruPlayPopulationPopulation StudyProteinsProtocols documentationRelapseReverse Transcriptase Polymerase Chain ReactionRoleSamplingSorting - Cell MovementSpecificitySystemT memory cellT-Cell ActivationT-LymphocyteT-Lymphocyte SubsetsTestingTranscriptTranslational ResearchTuberculosisVaccine DesignVitaminscohortcomparativeexomegene productgenetic variantin vivo Modelinfection riskinnovationmycobacterialnano-stringnew technologyprotein activationprotein expressiontechnology developmenttranslational studyvaccine development
中文摘要
T细胞在宿主对结核分枝杆菌感染的反应中起着关键作用,它们的抗原特异性形式是
广泛使用的临床免疫诊断试验的基础。MHC限制性效应记忆T细胞保护宿主
从进展到活动性结核病,但调节控制的特定效应功能是
未知。在秘鲁利马的一个特征良好的人类患者队列中,我们将确定
在高度纯化的效应记忆T细胞中测量到400个转录本的活动性结核病。文字记录
与疾病缺乏进展相关的将通过聚合酶链式反应和蛋白质测量来验证,以确定
可作为预防结核病进展的替代物和靶标的基因产品
免疫治疗的发展。目前几乎所有的技术开发工作都与佐剂有关
制剂、疫苗设计和免疫诊断主要集中在MHC抗原提呈分子上。然而,
最近的研究表明,非经典的CDIB和MRI蛋白存在分枝杆菌脂类和代谢物
T细胞在结核病中的作用。强调新的体外方法和CD1四聚体,我们将测量
人外周血中脂类和代谢物特异性GEM T细胞和MAIT细胞增殖的关系
豚鼠感染和复发。特别是,我们建议(A)测量GEM T细胞的体外扩增
在人类急性结核感染期间(B)MAIT效应器功能的比较纳米串图谱
(C)使用CDIB四聚体检测豚鼠的CDIB限制性T细胞。这些
翻译研究试图建立第一个易驯化的体内CDIB功能和小动物模型
检测感染与不变T细胞激活之间的因果关系。绕过了基因的复杂性
人类MHC蛋白,由脂质和代谢物激活不变T细胞可能提供更一致的潜在
可用脂质和维生素代谢物检测或调节的结果(项目4)。
英文摘要
T cells play a critical role in the host response to Mtb infection, and are their antigen specificity forms the
basis of widely used clinical immunodiagnostic tests. MHC-restricted effector memory T cells protect the host
from progression to active TB disease, but the particular effector functions, which mediate control are
unknown. In a well characterized human patient cohort in Lima, Peru, we will determine the association of
active TB disease with 400 transcripts measured in highly purified effector memory T cells. Transcripts
associated with lack of disease progression will be validated by PCR and protein measurements to define
gene products that can be measured as surrogates for protection from TB progression and targets for
immunotherapy development. Nearly all current technology development efforts related to adjuvant
formulation, vaccine design and immunodiagnosis focus on MHC antigen presenting molecules. However,
recent studies show that non-classical CDIb and MRI proteins present mycobacterial lipids and metabolites
to T cells in TB disease. Emphasizing new ex vivo methods and CD1 tetramers, we will measure the
relationship of expansion of lipid- and metabolite-specific GEM T cells and MAIT cells during human and
guinea pig infection and relapse. In particular, we propose to (a) measure GEM T cell expansion ex vivo
during acute human tuberculosis infection (b) comparative nanostring profiling of effector functions of MAIT
cells and GEM T cells, and (c) detect CDIb-restricted T cells in guinea pigs using CDIb tetramers. These
translational studies seek to establish the first tractable small animal model of in vivo CDIb function and
detect a causal relationship of infection with invariant T cell activation. Bypassing the genetic complexities of
human MHC proteins, activation of invariant T cells by lipids and metabolites offers potentially more uniform
outcomes that could be detected or modulated with lipids and vitamin metabolites (Project 4).
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Bacterial Determinants of Treatment Response in Mycobacteria Tuberculosis
-
批准号:10595535
-
项目类别:
-
资助金额:$291.67万
-
财政年份:2019
-
负责人:MEGAN B MURRAY
-
依托单位:
Bacterial Determinants of Treatment Response in Mycobacteria Tuberculosis
-
批准号:10390297
-
项目类别:
-
资助金额:$297.1万
-
财政年份:2019
-
负责人:MEGAN B MURRAY
-
依托单位:
Clinical Studies
-
批准号:10595536
-
项目类别:
-
资助金额:$140.94万
-
财政年份:2019
-
负责人:MEGAN B MURRAY
-
依托单位:
Gerome Wide Association Study of Bacterial Determinants of Clinical Response in Tuberculosis
-
批准号:10390299
-
项目类别:
-
资助金额:$99.03万
-
财政年份:2019
-
负责人:MEGAN B MURRAY
-
依托单位:
Clinical Studies
-
批准号:10390298
-
项目类别:
-
资助金额:$99.04万
-
财政年份:2019
-
负责人:MEGAN B MURRAY
-
依托单位:
Bacterial Determinants of Treatment Response in Mycobacteria Tuberculosis
-
批准号:9918252
-
项目类别:
-
资助金额:$293.63万
-
财政年份:2019
-
负责人:MEGAN B MURRAY
-
依托单位:
Gerome Wide Association Study of Bacterial Determinants of Clinical Response in Tuberculosis
-
批准号:10595537
-
项目类别:
-
资助金额:$306.4万
-
财政年份:2019
-
负责人:MEGAN B MURRAY
-
依托单位:
Bioinformatics Core
-
批准号:10089394
-
项目类别:
-
资助金额:$27.94万
-
财政年份:2015
-
负责人:MEGAN B MURRAY
-
依托单位:
A multi-disciplinary approach to the identification of host metabolic determinan
-
批准号:10089386
-
项目类别:
-
资助金额:$78.95万
-
财政年份:2015
-
负责人:MEGAN B MURRAY
-
依托单位:
Human Subjects Core
-
批准号:10089392
-
项目类别:
-
资助金额:$11.95万
-
财政年份:2015
-
负责人:MEGAN B MURRAY
-
依托单位:
Integrated discovery and development of innovative TB Diagnostics
-
批准号:9017912
-
项目类别:
-
资助金额:$581.92万
-
财政年份:2014
-
负责人:MEGAN B MURRAY
-
依托单位:
Integrated discovery and development of innovative TB Diagnostics
-
批准号:8642328
-
项目类别:
-
资助金额:$595.66万
-
财政年份:2014
-
负责人:MEGAN B MURRAY
-
依托单位:
Real-time surveillance to support dynamic and predictive models of MDR/XDR TB
-
批准号:7391377
-
项目类别:
-
资助金额:$46.59万
-
财政年份:2008
-
负责人:MEGAN B MURRAY
-
依托单位:
Genetic and metabolic determinants of multiple drug resistance in tuberculosis
-
批准号:7681506
-
项目类别:
-
资助金额:$62.98万
-
财政年份:2008
-
负责人:MEGAN B MURRAY
-
依托单位:
Real-time surveillance to support dynamic and predictive models of MDR/XDR TB
-
批准号:7681507
-
项目类别:
-
资助金额:$55.03万
-
财政年份:2008
-
负责人:MEGAN B MURRAY
-
依托单位:
Epidemiology and transmission dynamics of MDR/XDR tuberculosis
-
批准号:7499066
-
项目类别:
-
资助金额:$276.07万
-
财政年份:2007
-
负责人:MEGAN B MURRAY
-
依托单位:
Epidemiology and transmission dynamics of MDR/XDR tuberculosis
-
批准号:7936254
-
项目类别:
-
资助金额:$289.02万
-
财政年份:2007
-
负责人:MEGAN B MURRAY
-
依托单位:
Epidemiology and transmission dynamics of MDR/XDR tuberculosis
-
批准号:8136609
-
项目类别:
-
资助金额:$239.9万
-
财政年份:2007
-
负责人:MEGAN B MURRAY
-
依托单位:
Epidemiology and transmission dynamics of MDR/XDR tuberculosis
-
批准号:7347787
-
项目类别:
-
资助金额:$259.66万
-
财政年份:2007
-
负责人:MEGAN B MURRAY
-
依托单位:
Epidemiology and transmission dynamics of MDR/XDR tuberculosis
-
批准号:7681508
-
项目类别:
-
资助金额:$281.52万
-
财政年份:2007
-
负责人:MEGAN B MURRAY
-
依托单位:
海外基金